Streetbeat News

Stock Prices

AMKBY

ZIM

Zim Integrated Shipping Services Ltd. (NYSE:ZIM) stock is trading lower due to turmoil in the Red Sea, affecting shipping routes and causing uncertainty in the industry. Moller Maersk (OTCPK:AMKBY) also reported earnings and warned of future uncertainties due to the Red Sea crisis, leading the industry lower. The crisis has led to immediate capacity constraints and temporary rate increases, but an oversupply in shipping capacity is expected to eventually pressure prices. Attacks by Iran-backed Houthi militia have forced shipping companies to reroute, potentially impacting global inflation.

Portfolio Pulse from Erica Kollmann

February 08, 2024 | 8:54 pm

ARKK

NVDA

SARK

TARK

TSLA

Cathie Wood's ARK Invest, known for its bold investments in companies like Tesla and NVIDIA, and its bullish stance on Bitcoin, has been named the top 'wealth destroyer' by Morningstar. ARK Innovation ETF (ARKK) ranked 3rd in funds that depreciated the most over the last decade, with ARK's firm losing approximately $14.3 billion overall. Despite past successes, ARKK's value plummeted in the 2022 bear market. Options for investors include shorting ARKK through AXS Short Innovation Daily ETF (SARK) or leveraging with AXS 2X Innovation ETF (TARK).

Portfolio Pulse from Johnny Rice

February 08, 2024 | 8:53 pm

CG

JP Morgan analyst Kenneth Worthington maintains an Overweight rating on Carlyle Group (NASDAQ:CG) and raises the price target from $39 to $45.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 8:51 pm

MA

Mastercard (NYSE:MA) has seen a balanced mix of bullish and bearish options trading, with a notable focus on a price range between $400 and $600. Analysis of unusual trades revealed an equal split between bullish and bearish sentiments. The company, a global payment processor with over $8 trillion in transactions in 2022, currently has a stock price of $462.1, slightly up by 0.04%. Market experts have issued a consensus target price of $498.6 for Mastercard, with several analysts upgrading their ratings to Outperform.

Portfolio Pulse from Benzinga Insights

February 08, 2024 | 8:45 pm

BABA

Financial analysis of Alibaba Gr Holding (NYSE:BABA) options trading reveals a bearish sentiment among major investors, with 56% displaying bearish tendencies and 43% bullish. The trading activity suggests a price range of $50.0 to $200.0 for BABA over the next three months. The largest trades include both puts and calls with varying sentiments and strike prices. Alibaba, a leading online and mobile commerce company, saw its stock price decrease by -2.38%, with a current price of $71.89. Analysts have mixed ratings on BABA, with target prices ranging from $85 to $135.

Portfolio Pulse from Benzinga Insights

February 08, 2024 | 8:45 pm

CIGI

Colliers International Group's shares surged following the announcement of their Q4 financial results, which exceeded market expectations.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 8:45 pm

RXO

RXO shares declined following the announcement of disappointing Q4 revenue results. Additionally, B of A Securities downgraded RXO from Buy to Neutral and reduced its price target from $25 to $22.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 8:44 pm

UBER

Analysts from Needham, KeyBanc, RBC Capital, and Roth MKM have raised their price targets for Uber Technologies Inc (NYSE:UBER), citing better-than-expected fourth-quarter results, solid growth, and strategic gains. The raised targets reflect optimism about Uber's market position, EBITDA growth, and upcoming investor updates. UBER shares traded higher by 1.05% at $71.40.

Portfolio Pulse from Anusuya Lahiri

February 08, 2024 | 8:42 pm

COIN

MARA

RIOT

Shares of crypto-related stocks are trading higher amid strength in Bitcoin, indicating a positive correlation between the performance of Bitcoin and these stocks.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 8:41 pm

RNLX

Traders are closely watching Renalytix as analyst comments circulate suggesting that CMS has released a positive draft coverage determination for the company's proprietary KidneyIntelX test, leading to a spike in shares.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 8:40 pm